Cells degrade a novel inhibitor of differentiation with e1a-like properties upon exiting the cell cycle

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8889-8902

  Miyake, S ^a   Sellers, W R ^a   Safran, M ^a   Li, X ^a   Zhao, W ^a   Grossman, S R ^a   Gan, J ^a   Decaprio, J A ^a   Adams, P D ^a   Kaelin W G , Jr ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE; PROTEASOME; PROTEIN EID 1; PROTEIN MDM2; PROTEIN P300; RETINOBLASTOMA PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; ADENOVIRUS E1A PROTEINS; AMINO ACID SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CLONING, MOLECULAR; CREB-BINDING PROTEIN; DOWN-REGULATION; HISTONE ACETYLTRANSFERASES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINS;

EID: 0034458872     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8889-8902.2000     Document Type: Article

References (77)

1. Suppression of human colorectal carcinoma cell growth by wild-type p53
2. The CBP co-activator is a histone acetyltransferase
3. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha
4. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines
5. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
6. High-efficiency transformation of mamalian cells by plasmid DNA
7. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
8. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene
9. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
10. Phosphorylated CREB binds specifically to the nuclear protein CBP
11. The ubiquitin-proteasome pathway: On protein death and cell life
12. Requirement for a functional Rb-1 gene in murine development
13. Synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation
14. SCF and Cullin/Ring H2-based ubiquitin ligases
15. The regulation of E2F by pRB-family proteins
16. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor
17. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation
18. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex
19. Functional domains of the human glucocorticoid receptor
20. Conjunction dysfunction: CBP/p300 in human disease
21. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
22. Histone acetyltransferase complexes
23. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
24. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
25. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
26. Mdm2 promotes the rapid degradation of p53
27. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression
28. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F
29. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
30. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
31. Association of pl9ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
32. RB regulates the stability and the apoptotic function of p53 via MDM2
33. The retinoblastoma protein region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences
34. Effects of an Rb mutation in the mouse
35. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein
36. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
37. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
38. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
39. Functions of the retinoblastoma protein
40. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
41. Regulation of p53 stability by Mdm2
42. Substrate targeting in the ubiquitin system
43. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
44. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
45. A novel Rb- and p300-binding protein inhibits transactivation by MyoD
46. p300 gene alterations in colorectal and gastric carcinomas
47. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
48. The transcriptional coactivators p300 and CBP are histone acetyltransferases
49. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations
50. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator
51. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
52. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
53. Identification of a growth suppression domain within the retinoblastoma gene product
54. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
55. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells
56. The retinoblastoma protein contains a potent transrepression domain which induces a cell-cycle block when bound to DNA
57. RB as a modulator of transcription
58. Role of the retinoblastoma protein in the pathogenesis of human cancer
59. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
60. Cancer cell cycles
61. Regulation of differentiation by HBP1, a target of the retinoblastoma protein
62. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor
63. Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein
64. Steroid receptor coactivator-1 is a histone acetyltransferase
65. Abnormal skeletal patterning in embryos lacking a single Cbp allele: A partial similarity with Rubinstein-Taybi syndrome
66. RB kinases and RB-binding proteins: New points of view
67. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes
68. HBP1: A HMG box transcriptional repressor that is targeted by the retinoblastoma family
69. Chromatin remodeling and transcription
70. Degradation of CFTR by the ubiquitin-proteasome pathway
71. The retinoblastoma protein and cell cycle control
72. Doisruption of retinoblastoma protein function by coexpression of its C pocket fragment
73. Interaction between the retinoblastoma protein and the oncoprotein mdm2
74. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
75. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
76. Human p300 protein is a coactivator for the transcription factor MyoD
77. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis